Key result
NAFLD is independently linked to higher risk of AF, ventricular arrhythmias, and conduction disorders.
Why the study?
Does non-alcoholic fatty liver disease increase the risk of cardiac arrhythmias and conduction disorders?
Does non-alcoholic fatty liver disease increase the risk of cardiac arrhythmias and conduction disorders?
NAFLD is an independent risk factor for various cardiac arrhythmias and conduction disorders, highlighting the importance of electrocardiographic monitoring in these patients.
Answers are grounded in this paper and cite their sources.
May warrant arrhythmia monitoring in NAFLD; leaves open causal mechanisms and intervention effects.
Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of ventricular arrhythmias and cardiac conduction disorders, especially in patients with type 2 diabetes mellitus (DM2). The association between NAFLD and an increased risk of atrial fibrillation (AF) does not depend on common cardiometabolic risk factors and traditional AF risk factors. Structural, electrical and vegetative remodeling of the heart, characteristic of NAFLD, is a potential cause of its arrhythmogenic damage.
No takes yet. Share an insight, caveat, or question.
Стаценко et al. (2023) conducted a review in Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic fatty liver disease vs. Absence of non-alcoholic fatty liver disease was evaluated. Non-alcoholic fatty liver disease is associated with an increased risk of atrial fibrillation, ventricular arrhythmias, and cardiac conduction disorders, independent of traditional risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: